Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Stock news
Yahoo Finance’s Jared Blikre, Brian Sozzi, Julie Hyman, and Myles Udland preview the GameStop Congressional hearing happening today.
A House Financial Services Committee hearing about the GameStop trading frenzy, scheduled for Feb. 18, will shine a light on Robinhood and stock trading.
ANN ARBOR, Mich., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that the underwriter of its previously announced public offering of has exercised in full its over-allotment option to purchase an additional 13,697,368 common shares of Zomedica at a price to the public of $1.90 per share, less underwriting discounts and commissions. Afte...
TransEnterix (NYSEAMERICAN:TRXC) is yet another small cap “story stock” that’s gone from zero to sixty. Since January, shares have zoomed from around $1.17 per share, to around $7 per share as of this writing. But, is it just hype pushing shares higher? Or, is there compelling evidence this company, which stumbled massively in 2018 and 2019, is finally ready for prime time? Source: Dmytro Zinkevych / Shutterstock.com Consider it a bit of both. One one hand, recent success its seen with its Senha...
ANN ARBOR, Mich., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that the closing of its previously announced public offering of 91,315,790 common shares of Zomedica, at a price to the public of $1.90 per share, less underwriting discounts and commissions. As previously announced, Zomedica also has granted to the underwriter a 30-day op...
Shares of Zomedica Corp. tumbled 17.0% in premarket trading Tuesday, after the veterinary health company's common stock offering, that was upsized by nearly seven-fold, priced at a deep discount. Trading volume of 40.1 million shares made Zomedica's stock the most actively traded ahead of the open. The company said overnight that the sole book-running manager for the offering, H.C. Wainwrite & Co. agreed to increase the size of the public offering "due to demand" to 91.3 million shares at a pric...
ANN ARBOR, Mich., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 91,315,790 common shares of Zomedica, at a price to the public of $1.90 per share, less underwriting discounts and commi...
ANN ARBOR, Mich., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 13,157,895 common shares of Zomedica, at a price to the public of $1.90 per share, less underwriting discounts a...